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Abstract
Recent studies suggest that only endothelium-attached malignant cells are capable of giving rise to hematogenous cancer
metastases. Moreover, tumor cell adhesion to microvascular endothelium could be crucial in metastasis predilection to
specific organs or tissues. However, the existing in vitro and in vivo techniques do not provide for sufficient delineation of
distinct stages of a dynamic multi-step intravascular adhesion process. Here we report the development of an experimental
system allowing for prolonged continuous ex vivo real-time observation of malignant cell adhesive interactions with perfused
microvessels of a target organ in the context of its original tissue. Specifically, the vasculature of excised dura mater perfused
with prostate cancer cells is described. An advantage of this technique is that selected fluorescently labeled tumor cells can be
followed along identified vascular trees across the entire tissue specimen. The techniques provide for superior microvessel
visualization and allow for uninterrupted monitoring and video recording of subsequent adhesion events such as rolling,
docking (initial reversible adhesion), locking (irreversible adhesion), and flattening of metastatic cancer cells within perfused
microvasculature on a single cell level. The results of our experiments demonstrate that intravascular adhesion of cancer cells
differs dramatically from such of the leukocytes. Within dura microvessels perfused at physiological rate, non-interacting,
floating, tumor cells move at velocities averaging 7.2×103 µm/s. Some tumor cells, similarly to leukocytes, exhibit rolling-
like motion patterns prior to engaging into more stable adhesive interactions. In contrast, other neoplastic cells became
stably adhered without rolling showing a rapid reduction in velocity from 2 × 103 to 0 µm/s within fractions of a second.
The experimental system described herein, while developed originally for studying prostate cancer cell interactions with
porcine dura mater microvasculature, offers great flexibility in adhesion experiments design and is easily adapted for use
with a variety of other tissues including human.
Introduction
Discovering the molecular mechanisms underpinning cancer
metastasis is one of the most important goals of modern
cancer research. After metastatic cancer cells escape the
primary tumor and enter a circulation, interactions of blood
borne malignant cells with microvascular endothelium rep-
resent the first and rate-limiting step in establishing of sec-
ondary metastatic lesions. Recently, it was shown that only
endothelium-attached tumor cells are capable of giving rise
to hematogenous metastases [1]. These results underscored
the critical importance of tumor-endothelial cell interactions
in metastatic cancer spread.
Many important facts regarding cancer cell adhesion
to endothelia were revealed in vitro, using static adhesion
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assays and parallel flow chamber techniques, or in vivo,
employing intravital video microscopy [2]. Yet, the existing
in vitro and in vivo experimental approaches have numerous
major limitations. Most importantly, they do not allow for
a sufficient delineation of the specific functions of different
adhesion molecules at distinct stages of cancer metastasis as
well as for continuous monitoring of individual metastatic
cell interactions with intact host microvessels in the con-
text of its original tissue over a prolonged period of time.
However, studying adhesion processes without loss of their
original microenvironment and temporal dynamics is crucial
for obtaining the most accurate and reliable information [3].
Current models of cancer cell adhesion to the microvas-
culature describe it as a multi-step process including priming
(changes in the endothelium adhesiveness), docking (ini-
tial reversible cancer cell adhesion to the endothelium),
locking (irreversible adhesion involving protein-protein in-
teractions), followed by extravasation and/or intravascular
clonogenic growth [1, 4, 5]. A broad array of adhesion
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molecules such as carbohydrates, lectins, cadherins, and in-
tegrins participate at distinct stages of this process, whereas
the unique combination of the adhesion molecules expressed
on tumor and endothelial cells may predetermine the out-
come of both the adhesion and the metastatic process in
whole. Indeed, a possible role for these interactions in defin-
ing tissue specificity of breast and prostate cancer metastasis
was revealed [5–8]. For example, the preferential adhesion
of prostate cancer cells to bone marrow derived endothe-
lium was demonstrated [7], and two independent groups
have shown that human prostate cancer cells exhibit strik-
ing tissue specificity in humanized animal models of cancer
metastasis [9, 10]. These findings once again highlighted
the necessity of studying malignant cell adhesive interac-
tions with intact microvasculature of the specific organs and
tissues.
Here we report the development of the experimental sys-
tem allowing for a prolonged (up to several hours), continu-
ous ex vivo real time observation of malignant cells adhesive
interactions with perfused porcine microvessels. The use
of porcine tissue provides for studying cancer-endothelial
cell interactions with intact differentiated microvessels of
a large mammalian species exhibiting considerable well-
characterized similarities in microvascular physiology and
cellular biochemistry with humans [11]. Specifically, in
this study, we used dura mater, a tissue representing an
important site of intracranial malignant involvements tar-
geted frequently by prostate cancer metastasis (Figure 1A).
Although, until lately, the incidence of dura mater meta-
stases has been underreported, in a recent autopsy series of
men who died from advanced hormone-refractory prostate
cancer, metastatic tumors originated from dura mater were
found in 43% of the cases [12].
Our experiments demonstrated that intravascular can-
cer cell adhesion behavior differs dramatically from that of
leukocytes. Within dura mater microvasculature perfused
at physiological rate, non-interacting tumor cells moved at
high velocities averaging 7.19 × 103 µm/s. Whereas some
tumor cells, similarly to leukocytes, exhibited rolling-like
motion patterns prior to engaging into more stable adhesive
interactions; other became stably adhered without rolling,
showing a rapid reduction in velocity from 2×103 to 0 µm/s
within fractions of a second. It is well documented that
leukocytes adhere to the endothelia and escape microcircu-
lation in post capillary venules. In contrast, even though we
cannot completely rule out cancer cell adhesion to venu-
lar endothelium, we observed the prevailing majority of
neoplastic-endothelial cell adhesion in pre capillary arteri-
oles and capillaries. Moreover, even within the arterial part
of a vascular tree, tumor cell interactions with different
microvessels varied significantly. Further, neoplastic cell ad-
hesion behavior changes dynamically as they pass through
different segments of the same blood vessel.
In summary, our results demonstrate fundamental differ-
ences in intravascular adhesion behavior between metastatic
cancer cells and leukocytes suggesting that they could be
driven by distinct molecular mechanisms. The non-uniform
character of tumor cell adhesive interactions with differ-
ent microvessels highlights the importance of studying in
greater detail the role of the microvascular endothelium
adhesive properties in hematogenous cancer spread.
Materials and methods
Chemicals and reagents
Sylgard was purchased from Dow Corning Corp. (Mid-
land, Michigan, USA). Oregon GreenTM-514 was obtained
from Molecular Probes Inc. (Eugene, Oregon, USA). All
other reagents, including porcine serum albumin, were pur-
chased from Sigma Chemicals Co. (St. Louis, Missouri,
USA), unless otherwise specified.
Tissue acquisition and preparation
The dura mater tissue was acquired from 9–12 month-old
mature male Yucatan miniature swine undergoing cardi-
ology procedure in the course of an unrelated study. Dura
mater corresponding to one hemisphere (Figure 1B) was col-
lected within 15–30 min after animal’s sacrifice, and placed
immediately on ice in a porcine Krebs solution (Krebs
physiological salt supplemented with 1.0 mg/ml porcine al-
bumin). Special attention was paid to minimize dura mater
damage during its separation from the skull. The collected
dura was rinsed twice with ice-cold porcine Krebs solution,
and transferred to a refrigerated tissue dissection dish filled
with porcine Krebs solution and connected to a circulating
bath to maintain the sample temperature from 0 to 4 ◦C
during the dissection procedure.
In our experiments, the collected dura mater corres-
ponding to one hemisphere (Figure 1B) was dissected and
trimmed under control of a low-power stereomicroscope
SMZ-2B (Nikon, Japan) to remove arachnoid granulations
and release dura’s folds as to allow for a flattening tis-
sue sample onto Sylgard-coated 100-mm tissue culture dish
(Figure 1C). During the trimming, particular care was taken
not to damage major blood vessels detectable under stereo-
microscope. After choosing a point for cannulation on one
of the branches of a median meningeal artery (Figure 1C), a
2–3 mm incision in a top layer of dura was made, and ap-
proximately 5 mm long segment of the artery was separated
carefully from surrounding tissues. After that, the sample
was transferred onto the fluorescent microscope stage, and
the artery was cannulated using a pipette manufactured from
1 mm O.D. borosilicate glass capillary with 90 µm open-
ing at the tip. From this point on, the experiments were
performed at room temperature.
Human cancer cells
The DU-145 human prostate carcinoma cell line was ob-
tained from the American Type Culture Collection (Rock-
ville, Maryland, USA). The cells were maintained on plastic
in a humidified incubator in 5% CO2/95% air at 37 ◦C
as a monolayer culture using RPMI-1640 medium sup-
plemented with L-glutamine and 10% fetal bovine serum.
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Figure 1. A, dura mater metastatic lesions of a hormone-refractory adenocarcinoma of the prostate. B and C, porcine dura mater corresponding to one
hemisphere before (B) and after (C) dissecting and trimming to allow flattening on a Sylgard-coated tissue dish. Arrows indicate possible points for
connecting to the branches of the median meningeal artery. D through G, dura mater microvessel contrasting using Oregon Green-labeled porcine albumin
(D) and acridine orange (E–G). Acridine orange staining provides for permanent vessel contrasting leaving the vessel lumen free for observation of the
adhesion events (E). Upon staining with acridine orange arteries (F) and veins (G) exhibit distinct staining patterns. Note presence of the smooth muscle
nuclei oriented perpendicularly to the vessel axis on artery (F), whereas only endothelial cell nuclei oriented along the vessel axis could be seen on vein
(G). Scale bar: 100 µm.
Immediately prior to adhesion experiments, cancer cells
were prelabeled for 5 min with 3 µg/ml solution of acrid-
ine orange in RPMI-1640 medium, rinsed three times with
serum free RPMI-1640 medium, dissociated from plastic
using a nonenzymatic cell dissociation reagent (Sigma, St.
Louis, Missouri, USA), and pipetted to produce a single cell
suspension. To remove any remaining cell clumps, tumor
cell suspension was filtered through a 20-µm nylon mesh,
and adjusted to contain 5 × 104 cell/ml. A fresh neoplastic
cell suspension was prepared prior to every injection.
Vessel perfusion and contrasting
After connecting to one of the branches of Median Men-
ingeal artery (typically 300–500 µm I.D.), dura mater
vasculature was perfused for 20 min with porcine Krebs
solution using a precision syringe infusion/withdrawal pump
KDS210 (KD Scientific, USA) at physiological rate (typic-
ally 15–30 µl/min). The physiological flow rate was estim-
ated depending on vessel diameter based on literature data
[13]. To visualize the perfused vascular tree, microvessels
were perfused for additional 20–60 min either with porcine
Krebs solution containing Oregon Green-514-labeled por-
cine albumin (1.0 mg/ml final albumin concentration), or
with 0.3 µg/ml acridine orange solution in physiological
porcine Krebs or RPMI-1640 media supplemented with 10%
FBS and 1.0 mg/ml porcine albumin.
Video microscopy system
The video microscopy system was assembled on the basis
of a fixed stage fluorescent microscope Laborlux 8 (Leitz
Wetzlar, Germany), equipped with 75-watt Xenon illumin-
ator and FITC and Rhodamine filter cubes. Video images
were acquired with a high sensitivity monochrome solid-
state CCD video camera (COHU Inc., San Diego, California,
USA) and recorded using a Panasonic S-VHS videocassette
recorder AG-MD830 (Panasonic, Japan) at 30 frames per
second.
To enable the use of large tissue specimens, we designed
an original experimental platform mounted directly on a
fluorescent video microscope stage, capable of accommod-
ating 100 mm dish and bearing a ‘little giant’ series three-
dimensional micromanipulator (Narishige, Japan) coupled
with an injector connected to the precision infusion pump.
Introducing an inline low-pressure chromatography injector
with all-teflon wetted parts (Rheodyne Model 50200, Rheo-
dyne, USA), connected directly to the pipette, allows for
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Figure 2. The appearance of non-interacting (A, B), interacting (rolling) (C, D), and stably adhered (E, F) cancer cells in a perfused porcine dura mater
vasculature. Non-interacting (floating) cells at a physiological perfusion rate appear as a smear on a still frame. Two different floating cancer cells indicated
by arrows, which passed through the same part of the vascular tree within 0.2 s from each other are shown in A and B. In contrast, interacting (rolling)
cell moves significantly slower with frequent interruptions and stops (C, D). The difference between frames C and D is 0.7 s, during which tumor cell
(arrows) covered the distance of approximately 70 µm. E and F, stably adhered cancer cell (arrows), which remains stationary in a microvasculature for
a prolonged period of time. The difference between frames E and F is greater than 1.5 min. G, Stably adhered prostate cancer cells flattened within dura
mater microvasculature after 4 h of perfusion. Scale bars: 50 µm; scale bar in B for frames A through D, scale bar in F for frames E and F.
injecting neoplastic cells in a precise volume, defined by
a sample loop size, without interrupting perfusion. The
platform allows for injecting a defined amount of fluores-
cently labeled tumor cells and monitoring their interactions
with dura’s microvasculature across the entire dura mater
specimen corresponding to the whole hemisphere.
Image processing and data analysis
For subsequent frame-by frame analysis, the recorded ana-
log video images were digitized using a media converter
DVMC-DA2 (Sony, Japan) and Adobe Premier 6 software
(Adobe Systems Inc., San Jose, California, USA). For
better visual perception, the selected frames were pseudo
colored using Adobe Photoshop 5.5 (Adobe Systems Inc.,
San Jose, California, USA) and MetaMorph Immaging Sys-
tem (Universal Imaging, Hallis, New Hampshire, USA)
software.
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Results and discussion
Blood vessel contrasting and visualization
The traditional approach to contrasting and visualizing a
perfused microvasculature would be to inject one of the
commonly used fluorophores such as FITC or fluorophore-
tagged proteins such as Oregon Green- or Texas Red-labeled
albumin [14]. The infusion of the fluorophore-labeled pro-
tein solution allows for sufficient visualization of a perfused
vascular tree (Figure 1D), however, this technique only
provides for transient microvessel contrast, which disap-
pears as soon as the fluorophore is washed away. In addi-
tion, high background fluorescence of the vessel-contrasting
compound interferes with the observation of intravascular
adhesion events.
To overcome these limitations, we developed an original
method for visualizing the microvasculature by perfusing it
for 20–60 min (depending on a size of a perfused vascular
tree) with a weak (0.3 µg/ml) acridine orange solution (Fig-
ure 1E). For our experiments, this technique provides several
advantages over visualizing microvessels using fluorophore-
labeled proteins. First, it results in a rapid and permanent
staining of endothelial and smooth muscle cell nuclei allow-
ing for viewing of perfused microvasculature in great detail.
Importantly, photobleaching caused by prolonged illumin-
ation is insignificant, as even after 4 to 5 h the perfused
vascular tree is clearly visible. Second, when focusing on
a vessel surface, it allows for distinguishing between ar-
teries and veins (Figures 1F and G) due to differences in
staining patterns. The arteries, in addition to endothelial cell
labeling, exhibit specific staining pattern due to the labeling
of the oriented perpendicularly to the vessels axis nuclei of
smooth muscle cells as well (Figure 1F). In contrast, only
endothelial cell nuclei oriented strictly along the vessel axis
could be seen on veins (Figure 1G). Third, the acridine
orange staining to a certain extent allows for the monitor-
ing of endothelial cells viability by periodically switching
to higher magnification and checking on some of the early
signs of apoptosis such as chromatin condensation or gen-
eration of single-stranded DNA specimens, which would
result in shifting of green fluorescence of the acridine or-
ange complexes with double-stranded DNA toward the red.
Most importantly, this labeling technique leaves the vessel
lumen free for observation of intravascular adhesion events.
In addition, pre-perfusing dura mater vasculature prior to
neoplastic cell injection, removes most blood elements from
microcirculation thus eliminating their impact on the results
of adhesion experiments.
Cancer cell injection, video microscopy, and subsequent
analysis of cancer cell interactions with microvasculature
Metastatic cancer cells, including DU-145 human prostate
carcinoma cells used in this study, posses enhanced homo-
typic aggregation ability [15]. Therefore, to prevent tumor
cells from adhering to each other and forming multicellular
clumps, it is important to prepare a single cell suspension
of fluorescently labeled cancer cells immediately prior to
injecting them. For same reason, it is highly desirable to
minimize the time of cancer cell passage through the plastic
tubes of the infusion system into the vasculature of the per-
fused tissue. To achieve this, we introduced a low-pressure
chromatography injector with all-teflon vetted parts imme-
diately next to the micromanipulator. This allowed us to
connect the ‘out’ port of the injector directly to the pipette
thus reducing the system ‘dead’ volume to approximately
80 µl. As a result, in our experiments, cancer cells appear
in a perfused microvasculature within 3 min post injection.
In addition, the inline injector allows for introduction of a
precise amount of cancer cells in exactly the same volume
defined by the size of a sample loop, as well as for mul-
tiple tumor cell injections at different time points without
interrupting perfusion. In our experiments, we routinely use
four to five 500 µl injections of cancer cell suspension with
30 min intervals between subsequent injections.
There are several options for monitoring and analyzing
intravascular adhesion events. After injecting fluorescently
labeled cancer cells, their adhesive interactions with mi-
crovasculature could be monitored and video recorded at
a predetermined location within the vascular tree over a
defined period of time. A subsequent frame-by-frame ana-
lysis is performed then to characterize the adhesion behavior
of cancer cells, which passed through the observed mi-
crovessels. When perfused at the physiological flow rate,
as measured in 90–100 µm in diameter arterioles, non-
interacting (floating) tumor cells move at a high velocity
averaging 7.19 × 103 ± 3.29 × 103 µm/s (range 1.6 × 103–
16.5 × 103 µm/s with 72.2% in a range from 5.1 × 103 to
9.4 × 103 µm/s), and appear on a still frame as a smear
(Figures 2A and B). Interestingly, at the beginning of the
experiments, high tumor cell velocity is accompanied by a
very low (3.3–3.7%) number of neoplastic cells interacting
with endothelium. However, after 3 to 4 rounds of tumor
cell injection (1.5–2 h of perfusion), the fraction of cancer
cells actively interacting with microvessel walls increases to
24.3%. At this time, abundant prostate cancer cell interac-
tions with dura mater microvessels, ranging from 110 µm
to less than 20 µm in diameter, become available for obser-
vation. In contrast to non-interacting (floating) cells, tumor
cells that interact with the vascular wall move at the ve-
locities ≤ 2.0 × 103 µm/s. According to hydrodynamic
studies, Poiseuille flow in blood vessels is characterized by a
parabolic profile with highest velocities along the centerline,
forcing larger free-floating particles, such as non-interacting
leukocytes or cancer cells, to the center of the stream [16,
17]. Therefore, described herein reduction in tumor cell ve-
locity reflects their displacement out of the center stream
toward the blood vessel wall and is indicative of tumor cell
interactions with microvascular endothelium. Upon circulat-
ing cell displacement toward the wall, both the shear force
and specific adhesive interactions will regulate the rolling re-
sponse [17]. For these reasons, we designated all tumor cells
moving at velocity ≤ 2 × 103 µm/s as interacting/rolling
cells. The interacting/rolling cells move significantly slower
(Figures 2C and D). Some of the interacting/rolling can-
cer cells engage into more stable adhesive interactions and
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Figure 3. (A) Fluorescently labeled prostate carcinoma cell exhibiting, similarly to leukocytes, rolling-like movement prior to engaging into stable adhesive
interactions. Time elapsed indicated at the bottom of each subsequent frame shown. Scale bar: 50 µm. (B and C) A composite image of 6 subsequent
frames (B) showing fast moving neoplastic cell, which abruptly stops and becomes permanently adhered without rolling (B, C). Numbers in boxes show
time code generator reading corresponding to each frame in hours, minutes, seconds, and frame numbers (30 frames/s) presented as hh:mm:ss:ff. Scale
bar: 100 µm.
remain stationary for extended (>30 s) periods of time (Fig-
ures 2E and F), or become permanently attached to the
vascular wall. In some cases, when permanent lodging oc-
curs in microvessels of a size comparable with tumor cells
(Figure 2G), it is hard to conclude whether neoplastic cell
arrest was caused by a mechanical trapping or by specific
adhesive interactions. On this basis, many have attributed
tumor cell arrest in microcirculation entirely to mechanical
mechanisms of size limitation. However, in many instances,
we observed permanent tumor cell attachment to the vas-
cular wall in microvessels far exceeding neoplastic cells
in diameter (Figures 2E, 3A and 4C). In these cases, a
mechanical factor could be clearly excluded, suggesting
that specific adhesive interactions between malignant cells
and endothelia mediate tumor cell arrest in the vasculature.
The extension of a perfusion time up to 4–5 h enables for
observing subsequent stages of the adhesion process result-
ing in malignant cells flattening on microvessels endothelia
(Figure 2G). Alternatively, after tumor cell injection, se-
lected individual neoplastic cells could be followed along
the vasculature, and changes in their adhesion behavior ob-
served and video recorded as they pass through different
microcirculation compartments.
Tumor cell intravascular adhesion behavior differs from
such of leukocytes
It is well documented that in leukocyte adhesion rolling is
the first and rate-limiting step ultimately required for stable
leukocyte adhesion to the endothelium [18]. In contrast,
our results demonstrated that, whereas some malignant cells
similarly to leukocytes exhibited rolling-like motion prior to
engaging into more stable adhesive interactions (Figure 3A),
other exhibited an adhesion behavior completely distinct
from such of white blood cells. These neoplastic cells, mov-
ing at the velocity as high as 2 × 103 µm/sec, stopped mo-
mentarily and became attached to the vascular wall within
fractions of a second (Figures 3B and C). Recently, we re-
ported similar adhesion behavior of highly metastatic MDA-
MB-435 human breast carcinoma cells in vitro in parallel
flow chamber experiments [19]. Interestingly, while there
was no difference between highly metastatic MDA-MB-435
and poorly metastatic MDA-MB-468 cells in their ability to
roll on microvascular endothelium, the MDA-MB-435 were
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Figure 4. A, composite picture of 12 consequent frames illustrating the movement of the interacting/rolling prostate cancer cell (arrows) along perfused
porcine dura mater microvasculature over 10.5 s period. Numbers in boxes show time code generator reading corresponding to each frame in hours,
minutes, seconds, and frame numbers (30 frames/s) presented as hh:mm:ss:ff. B, the dynamics of the velocity changes of rolling prostate cancer cell shown
in A over 10.5 s period. C, ‘hot spot’ within a pre-capillary arteriole harboring multiple cancer cells. Scale bar: 100 µm.
2–4-fold more adhesive to microvascular endothelium than
their low metastatic counterparts [19]. These observations
imply that, even though circulating malignant cells could roll
on microvascular endothelium, rolling is not a prerequisite
for their permanent adhesion to the vascular wall.
Importantly, we observed the vast majority of neoplastic
cell adhesive interactions in pre capillary arterioles and
capillaries. In contrast, leukocytes adhere to the endothe-
lium and escape microcirculation in post capillary venules.
Although, we cannot completely rule out tumor cell in-
teractions with venular endothelium, this is an important
observation suggesting that intravascular adhesion of tumor
cells and leukocytes could be governed by adhesion mo-
lecules differentially expressed on different microvessels. In
addition, even within arterial part of microcirculation, tu-
mor cells adhesive interactions with endothelium of different
microvessels or different segments of the same vessel var-
ied significantly. For example, when individual cancer cell
where followed along the vasculature, those that interacted
with endothelium moved in a specific manner characterized
by multiple discrete interruptions and rapid changes in ve-
locity ranging from 0 to 2000 µm/s, (Figures 4A and B). In
many instances, we observed multiple stably adhered tumor
cells located within relatively short segments of pre capillary
arterioles (Figure 4C), while the rest of the vessel as well as
neighboring microvessels remained free of neoplastic cells.
This observation suggests the existence of ‘hot spots’ within
a microcirculation of metastasis prone organs, exhibiting
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elevated ability to harbor metastatic cells compared to the
rest of the microvasculature. Uncovering the factors defin-
ing this ability could be of paramount importance for our
understanding of the molecular and cellular mechanisms
underpinning hematogenous cancer spread.
The technology described herein provides investigators
with great flexibility for studying metastatic cancer cell in-
teractions with the microvasculature of a target organ. Most
importantly, tumor cell adhesion could be studied in real
time using intact microvessels in their native state in the
context of the original tissue microenvironment, which war-
rants the persistence of the genuine adhesion molecules
expression profiles. Moreover, cancer cells interacting with
endothelia could be followed along the perfused vascular
tree, and distinct steps of the adhesion process could be
monitored continuously and video recorded over extended
periods of time. This in turn, using selective inhibitors
directed against various adhesion molecules expressed on
endothelial and cancer cells, would allow for delineating the
specific functions of different adhesion molecules at distinct
stages of the metastatic process. Most importantly, these
techniques produce consistent reproducible results, as we
persistently observed prostate cancer cell adhesion patterns
described herein in preparations from 15 animals.
While porcine dura mater was used in this study, this
technique could be adapted easily for the study of metastatic
tumor cell interactions with a variety of other porcine and
human soft tissues frequently involved in cancer metastasis.
The use of this technique will facilitate the uncovering of the
molecular and cellular mechanisms of tumor metastasis.
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